1631
|
|
|
CTP synthase 2 |
GATD5B |
|
1632
|
|
|
CTR9 component of Paf1/RNA polymerase II complex |
SH2BP1, TSBP, p150, p150TSP |
|
1633
|
|
|
Chymotrypsinogen B1 |
CTRB |
|
1634
|
|
|
Chymotrypsinogen B2 |
- |
|
1635
|
|
|
Chymotrypsin C |
CLCR, ELA4 |
|
1636
|
|
|
Chymotrypsin like |
CTRL1 |
|
1637
|
|
|
Cathepsin A |
GLB2, GSL, NGBE, PPCA, PPGB |
|
1638
|
|
|
Cathepsin B |
APPS, CPSB, KWE, RECEUP |
Alzheimer disease, Renal cell carcinoma, Diabetes mellitus, Glioblastoma, Irritable bowel syndrome, Leprosy, Metabolic syndrome, Myopathy, Necrosis, Neurotic disorder, Parkinson disease, Prostatic neoplasms, Proteinuria, Systemic lupus erythematosus, Diabetes mellitus type 1, Diabetes mellitus type 2View all (1 more) |
1639
|
|
|
Cathepsin C |
CPPI, DPP-I, DPP1, DPPI, HMS, JP, JPD, PALS, PDON1, PLS |
|
1640
|
|
|
Cathepsin D |
CLN10, CPSD, HEL-S-130P |
Alzheimer disease, Amyotrophic lateral sclerosis, Rheumatoid arthritis, Hepatocellular carcinoma, Renal cell carcinoma, Neuronal ceroid lipofuscinosis, Diabetic neuropathy, Kidney disease, Motor neuron disease, Osteoarthritis, Prostatic neoplasms, Retinitis pigmentosa |